Our Pricing

Omeprazole vs Lansoprazole UK

Published on: June 03, 2026

Choosing between omeprazole vs lansoprazole UK treatments for acid reflux can feel overwhelming, but both are highly effective proton pump inhibitors (PPIs) licensed by the MHRA. At Cured Pharmacy, our UK-registered clinical team helps you determine which PPI suits your symptoms, lifestyle, and medical history through a free online consultation taking under three minutes.

How Omeprazole and Lansoprazole Work for Acid Reflux

Both omeprazole and lansoprazole belong to the proton pump inhibitor (PPI) class, which works by blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This mechanism reduces stomach acid production by up to 90%, providing relief from heartburn, gastro-oesophageal reflux disease (GORD), and peptic ulcers within 24 to 48 hours of starting treatment [1][2].

The key difference lies in their chemical structure and metabolism. Omeprazole was the first PPI licensed in the UK in 1989, whilst lansoprazole followed in 1993 with a slightly different benzimidazole ring structure that some patients metabolise more efficiently [2]. Both medications require activation in the acidic environment of parietal cells, meaning they only work where stomach acid is actively being produced.

Clinical trials demonstrate comparable efficacy between the two PPIs, with healing rates for erosive oesophagitis reaching 80–90% after eight weeks of treatment at standard doses [3]. Your response depends on individual factors including CYP2C19 enzyme genetics, concurrent medications, and the severity of your reflux symptoms.

Omeprazole vs Lansoprazole: Key Differences

Whilst both medications achieve similar clinical outcomes, several practical differences may influence which PPI your UK prescriber recommends. Omeprazole is available from £9.99 at Cured Pharmacy in 10mg and 20mg capsules, making it the most cost-effective option for long-term acid reflux management. Lansoprazole capsules, available in 15mg and 30mg strengths from £9.99, offer an alternative for patients who experience inadequate relief or side effects with omeprazole.

Onset of action differs slightly between the two medications. Lansoprazole reaches peak plasma concentration approximately 1.5 to 2 hours after administration, compared to 2 to 4 hours for omeprazole [2]. In practice, most patients notice symptom improvement within the same timeframe regardless of which PPI they take, though some individuals report faster relief with lansoprazole.

Drug interactions also vary between omeprazole and lansoprazole due to differences in hepatic metabolism. Omeprazole is a moderate inhibitor of CYP2C19 and may interact more significantly with clopidogrel, diazepam, and warfarin [4]. Lansoprazole shows fewer clinically significant interactions, which may make it preferable if you're taking multiple medications.

Formulation and Administration Differences

Omeprazole capsules contain enteric-coated granules that protect the active ingredient from stomach acid until it reaches the small intestine. Lansoprazole uses similar gastro-resistant technology but is also available as Zoton FasTab, an oro-dispersible formulation that dissolves on the tongue without water — ideal for patients with swallowing difficulties or those who prefer not to take capsules [2]. Both medications should be taken 30 minutes before food for optimal absorption and acid suppression throughout the day.

Which Is More Effective: Omeprazole or Lansoprazole?

Head-to-head clinical trials show no statistically significant difference in efficacy between omeprazole 20mg and lansoprazole 30mg for treating GORD, with both achieving heartburn relief in approximately 80% of patients after four weeks [3]. A systematic review published in Alimentary Pharmacology & Therapeutics found that lansoprazole 30mg and omeprazole 20mg produced equivalent healing rates for erosive oesophagitis, with symptom resolution occurring in similar timeframes [3].

Individual response varies based on genetic factors, particularly CYP2C19 polymorphisms that affect PPI metabolism. Approximately 15–20% of the UK population are rapid metabolisers who break down omeprazole quickly, potentially reducing its effectiveness [4]. These patients may achieve better acid control with lansoprazole or alternative PPIs like esomeprazole, the S-isomer of omeprazole available from £9.99 at Cured Pharmacy.

For maintenance therapy in GORD, both medications demonstrate long-term efficacy when taken daily. NICE guidelines recommend starting with the lowest effective dose and stepping down after symptom control is achieved [5]. Your UK prescriber will review your treatment response after four to eight weeks and adjust your PPI choice or dosage accordingly.

Comparing Effectiveness for Specific Conditions

For Helicobacter pylori eradication therapy, both omeprazole and lansoprazole form part of triple therapy regimens with antibiotics, achieving eradication rates of 85–90% when combined with clarithromycin and amoxicillin [1]. Lansoprazole may offer a slight advantage in patients with severe peptic ulcer disease due to its faster onset of action, though clinical outcomes remain comparable. For Zollinger-Ellison syndrome and other hypersecretory conditions, higher doses of either PPI can be used safely under specialist supervision.

Side Effects: Omeprazole vs Lansoprazole

Both omeprazole and lansoprazole share a similar side effect profile, with most adverse reactions being mild and transient. Common side effects affecting up to 10% of patients include headache, nausea, abdominal pain, diarrhoea, and constipation [2]. These symptoms typically resolve within the first week of treatment and rarely require discontinuation.

Long-term PPI use beyond 12 months has been associated with potential risks including vitamin B12 deficiency, hypomagnesaemia, and a small increased risk of bone fractures in elderly patients taking high doses [4][5]. These risks apply equally to both omeprazole and lansoprazole, emphasising the importance of using the lowest effective dose for the shortest necessary duration. Your UK prescriber will review your need for ongoing PPI therapy regularly.

Rare but serious side effects include severe skin reactions (Stevens-Johnson syndrome), acute interstitial nephritis, and subacute cutaneous lupus erythematosus [2]. If you develop unexplained rash, joint pain, or changes in urination whilst taking either medication, contact your GP or pharmacist immediately. At Cured Pharmacy, our clinical team is available on (+44) 116 4646009 for any concerns about your treatment.

Choosing Between Omeprazole and Lansoprazole

Your choice between omeprazole and lansoprazole depends on several individual factors that your UK prescriber will assess during your online consultation. If cost is a primary concern and you have no previous PPI experience, omeprazole represents the most economical starting option. Patients who've tried omeprazole without adequate relief may benefit from switching to lansoprazole or alternative PPIs like pantoprazole or esomeprazole.

Consider lansoprazole if you take medications that interact significantly with omeprazole, particularly clopidogrel for cardiovascular protection. The FasTab formulation also makes lansoprazole ideal if you have dysphagia or prefer not to swallow capsules. For patients requiring rapid symptom control before endoscopy or those with severe oesophagitis, lansoprazole's slightly faster onset may provide marginal benefit.

Ultimately, both medications are safe and effective when used appropriately under clinical supervision. The UK prescriber conducting your consultation will review your medical history, current medications, symptom severity, and treatment goals to recommend the most suitable PPI. All prescription medications at Cured Pharmacy require this clinical assessment to ensure safe, personalised care.

Starting Your Treatment at Cured Pharmacy

Our streamlined online consultation takes under three minutes and covers your reflux symptoms, previous treatments, allergies, and concurrent health conditions. Once approved by a UK-registered prescriber, your medication is dispensed by our GPhC-registered pharmacy (9012511) and delivered in discreet packaging with next-day options available. We stock both branded and generic formulations, including Losec (branded omeprazole) from £9.99 and Zoton FasTab (branded lansoprazole) from £9.99, alongside cost-effective generic alternatives.

Alternative Acid Reflux Treatments Available

Beyond omeprazole and lansoprazole, Cured Pharmacy offers a comprehensive range of PPIs and acid reflux treatments to suit different clinical needs. Pantoprazole gastro-resistant tablets provide an alternative for patients experiencing side effects with other PPIs, whilst esomeprazole offers enhanced acid suppression through its purified S-isomer formulation [1].

For milder, intermittent heartburn, Pyrocalm 20mg (omeprazole) is available for short-term use without ongoing prescription, though a pharmacist consultation is required for first-time buyers. Nexium 40mg (branded esomeprazole) represents a premium option for patients requiring maximum acid suppression or those who prefer branded medications with extensive clinical trial data.

Your UK prescriber may also recommend lifestyle modifications alongside PPI therapy, including elevating the head of your bed, avoiding trigger foods, maintaining a healthy weight, and not eating within three hours of bedtime. These non-pharmacological approaches can enhance PPI effectiveness and may allow dose reduction over time [5].

Scientific References

1. Shin, J. M., & Kim, N. (2013). Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. Journal of Neurogastroenterology and Motility, 19(1), 25–35. https://doi.org/10.5056/jnm.2013.19.1.25 [accessed 13 August 2026]
2. Stedman, C. A., & Barclay, M. L. (2000). Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963–978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
3. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 640–647. https://doi.org/10.1038/clpt.2009.23 [accessed 13 August 2026]
4. Kwok, C. S., et al. (2010). Adverse effects of proton pump inhibitors. Expert Opinion on Drug Safety, 9(6), 879–894. https://doi.org/10.1517/14740338.2010.524924 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
6. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.